Wachtell and Cravath lead for Pfizer/Mylan merger
Credit: iStock/Gannet77
Pfizer and Mylan have tapped Wachtell Lipton Rosen & Katz and Cravath Swaine & Moore, respectively, to oversee the proposed combination of Pfizer’s Upjohn and generic drugmaker Mylan.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now